Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
OCLS [NASD]
Oculus Innovative Sciences, Inc.
Index- P/E1.81 EPS (ttm)0.81 Insider Own0.20% Shs Outstand8.66M Perf Week-0.81%
Market Cap12.73M Forward P/E- EPS next Y-0.68 Insider Trans53.00% Shs Float8.46M Perf Month-17.42%
Income6.10M PEG- EPS next Q-0.18 Inst Own10.00% Short Float5.49% Perf Quarter-35.53%
Sales12.90M P/S0.99 EPS this Y141.50% Inst Trans-6.18% Short Ratio6.31 Perf Half Y-49.66%
Book/sh1.58 P/B0.93 EPS next Y-11.50% ROA35.40% Target Price7.50 Perf Year-58.59%
Cash/sh0.40 P/C3.64 EPS next 5Y- ROE57.70% 52W Range1.33 - 5.99 Perf YTD-57.76%
Dividend- P/FCF- EPS past 5Y15.70% ROI-49.20% 52W High-73.27% Beta1.05
Dividend %- Quick Ratio1.40 Sales past 5Y20.50% Gross Margin55.80% 52W Low20.38% ATR0.15
Employees31 Current Ratio1.60 Sales Q/Q-19.50% Oper. Margin-51.90% RSI (14)50.40 Volatility13.08% 9.37%
OptionableNo Debt/Eq0.00 EPS Q/Q61.90% Profit Margin47.30% Rel Volume1.06 Prev Close1.47
ShortableYes LT Debt/Eq0.00 EarningsNov 19 AMC Payout0.00% Avg Volume73.66K Price1.60
Recom2.00 SMA204.69% SMA50-6.54% SMA200-41.61% Volume73,105 Change8.91%
Apr-19-13Reiterated Maxim Group Buy $2.80 → $6
Dec-14-10Initiated Rodman & Renshaw Mkt Outperform $3
Aug-18-09Initiated Dawson James Buy $4.50
Nov-07-08Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Aug-06-08Reiterated Rodman & Renshaw Mkt Outperform $14 → $12
Apr-11-08Reiterated Rodman & Renshaw Mkt Outperform $16 → $14
Jul-18-07Reiterated Rodman & Renshaw Mkt Outperform $13 → $16
Jun-21-07Initiated Rodman & Renshaw Mkt Outperform $13
Mar-27-07Initiated Roth Capital Buy $10
Dec-18-14 08:08AM  NVN Therapeutics Launches EstraCool(TM) Dietary Supplement for Reduction of Menopausal Symptoms GlobeNewswire
Dec-08-14 04:48PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, EDGAR Online
Nov-21-14 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
Nov-15-14 07:07PM  10-Q for Oculus Innovative Sciences, Inc. Company Spotlight
Nov-13-14 04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015 GlobeNewswire
Nov-11-14 05:05AM  Oculus Innovative Sciences Commercializes Microcyn(R)-Based Solution and Hydrogel for Treatment of Mild-to-Moderate Acne in Europe GlobeNewswire
Nov-04-14 05:00AM  Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Scar Management Hydrogel GlobeNewswire
Oct-30-14 11:30AM  Soaring costs of competing in the global internet race at Financial Times
10:29AM  Dilemma: Should companies reinvest or buyback stock? at CNBC
08:12AM  Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Atopic Dermatitis Hydrogel GlobeNewswire
08:08AM  Oculus Innovative Sciences Announces Fiscal Second Quarter 2015 Financial Results and Conference Call GlobeNewswire
Sep-21-14 01:30PM  Science fiction a step closer as Oculus virtual reality headsets near release at Financial Times
Sep-16-14 08:08AM  Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of Four New Patents for Microcyn(R) Technology GlobeNewswire
Sep-12-14 04:12PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-10-14 08:08AM  Oculus Innovative Sciences Introduces Microcyn(R)-Based Over-the-Counter Advanced Scar Management Hydrogel in United States GlobeNewswire
Aug-12-14 04:15PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-07-14 04:20PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015 GlobeNewswire
Aug-01-14 04:27PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Jul-24-14 08:08AM  Oculus Innovative Sciences Announces Fiscal First Quarter 2015 Financial Results and Conference Call GlobeNewswire
Jun-30-14 04:31PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online
Jun-26-14 06:42PM  Ruthigen Poised To Hit It Out Of The Park at Seeking Alpha
Jun-16-14 11:15AM  Oculus Innovative Sciences Inc Stock Upgraded (OCLS) at TheStreet
Jun-13-14 10:08AM  [video] 10 exciting video games to look out for at CNBC -7.60%
Jun-12-14 05:06PM  Why Oculus Innovative Sciences (OCLS) Stock Is Lower In After-Hours Trading at TheStreet
05:01PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Revenues of $2.9 Million and Net Income of $7.5 Million for Fourth Quarter of Fiscal 2014 Primarily Due to Accounting Treatment of Ruthigen IPO Transaction GlobeNewswire
May-29-14 08:08AM  Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2014 Financial Results and Conference Call GlobeNewswire
May-07-14 08:08AM  NVN Therapeutics Launches Glucorein(TM) HOP Reproductive Support Dietary Supplement for Women GlobeNewswire
Apr-30-14 06:40PM  Temper Dow Growth Optimism on Volume Concerns at TheStreet
Apr-28-14 05:13PM  What a Dizzying Day in the Markets at TheStreet
Apr-22-14 08:08AM  Oculus Innovative Sciences' Partner, More Pharma, Launches Microcyn(R)-Based Oral and Throat Infection Treatment Product in Mexico GlobeNewswire
Apr-09-14 08:08AM  Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation GlobeNewswire
Apr-02-14 04:55PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
08:08AM  Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO GlobeNewswire
Apr-01-14 05:05PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financi EDGAR Online +7.16%
Mar-27-14 08:20AM  Oculus appoints Cytokinetics CFO Sharon Barbari to board at theflyonthewall.com -9.19%
08:08AM  Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors GlobeNewswire
Mar-26-14 02:42PM  Why Oculus Innovative Sciences (OCLS) Stock Is Up Today at TheStreet +5.51%
02:36PM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
02:16PM  Midday movers: King Digital, Garmin, Corning & More at CNBC
12:52PM  A case of mistaken identity sends another Oculus soaring at MarketWatch
12:41PM  What's in the name Oculus? at Financial Times
12:19PM  On The Fly: Midday Wrap at theflyonthewall.com
12:02PM  Whoops! Stocks with Oculus name spike at CNNMoney.com
12:00PM  [video] Tech Yeah! Facebook moves into virtual reality at CNBC
11:30AM  Oculus Shares Up 152%, But It's Not That Oculus at The Wall Street Journal
11:25AM  Virtual Confusion: Unrelated Oculus Companies Rally on Facebook Buy at Fox Business
11:15AM  Oops! Wrong Oculus shares skyrocket at CNBC
10:49AM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
10:06AM  Two Stocks That Sound Like Oculus Are Going Bonkers For Some Reason Business Insider
Mar-25-14 05:06PM  [video] Facebook acquires Oculus for $2 billion at CNBC -6.78%
Mar-21-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP -11.99%
Mar-17-14 01:09PM  Why Oculus Could Trade Higher Within 2 Weeks at Seeking Alpha +12.84%
Mar-14-14 01:25PM  5 Stocks Poised for Breakouts at TheStreet +9.27%
Feb-27-14 08:08AM  Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors GlobeNewswire +9.27%
Feb-26-14 04:31PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors EDGAR Online
Feb-21-14 10:00PM  Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering GlobeNewswire +9.37%
Feb-19-14 08:16AM  Oculus receives approval for oral, throat infection products in Mexico theflyonthewall.com +20.63%
08:08AM  Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico GlobeNewswire
Feb-14-14 04:34PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-13-14 04:37PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:25PM  Oculus Innovative Sciences, Inc. Discusses Q3 2014 Results (Webcast) at Seeking Alpha
04:05PM  Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014 GlobeNewswire
Feb-06-14 04:39PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors EDGAR Online
04:05PM  Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc. GlobeNewswire
Feb-04-14 09:13AM  Story Stocks from Briefing.com Briefing.com
08:08AM  Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne GlobeNewswire
Jan-30-14 08:08AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call GlobeNewswire
Jan-07-14 08:08AM  Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market GlobeNewswire +8.66%
Dec-30-13 08:08AM  Oculus Innovative Sciences Receives Notification of Compliance With the Stockholders' Requirement of the NASDAQ Listing Rules GlobeNewswire
Dec-19-13 08:08AM  Oculus Innovative Sciences Pays Off Debt to Strengthen Balance Sheet; Obtains $4.5 Million in Stockholders' Equity on a Pro Forma Basis as of September 30, 2013, Sufficient to Regain Compliance with NASDAQ Listing Rules GlobeNewswire
Dec-18-13 08:39AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru EDGAR Online
Dec-17-13 08:08AM  NVN Therapeutics Launches New Tropical Flavor Glucorein(TM) Medical Food for Dietary Management of Polycystic Ovary Syndrome (PCOS) GlobeNewswire -5.66%
Dec-16-13 08:18AM  Ampio's Failed Drug Partner Talks Forces Spin-Out Plan at TheStreet
Dec-12-13 08:08AM  Oculus Innovative Sciences Receives Mexican Ministry of Health Approval of Microcyn(R)-Based Hydrogel for Management of Scars GlobeNewswire
Dec-06-13 04:33PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
Dec-05-13 03:40PM  Oculus Gains on Scar Product Approval Zacks -12.03%
02:24AM  InPlay: Oculus Innovative Sciences announces $2.2 mln securities offering; includes 550K shares at $4.00 per share with no warrant coverage Briefing.com
Dec-04-13 11:00PM  Oculus Innovative Sciences, Inc. Announces $2.2 Million Securities Offering GlobeNewswire +103.43%
06:02PM  Nasdaq stocks posting largest percentage increases AP
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and non-prescription products based on its Microcyn platform technology for the dermatology, surgical, advanced wound and tissue care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. The Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of organisms that cause disease, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human advanced wound and tissue care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand. The company's Microcyn has received eight 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, it provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. Oculus Innovative Sciences, Inc. sells its products directly, and through contract sales organization and distributors to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists for the treatment of various skin afflictions. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is headquartered in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schutz James JChief Executive OfficerNov 17Buy1.786,28511,18720,885Nov 17 04:31 PM